Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Glioblastoma and Mos[original query] |
---|
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro-oncology 2016 Aug . Nguyen HuyTram N, Lie Amy, Li Tie, Chowdhury Reshmi, Liu Fei, Ozer Byram, Wei Bowen, Green Richard M, Ellingson Benjamin M, Wang He-Jing, Elashoff Robert, Liau Linda M, Yong William H, Nghiemphu Phioanh L, Cloughesy Timothy, Lai Albe |
The role of ABO blood groups in glial neoplasms. British journal of neurosurgery 2019 Feb 33 (1): 43-46. Alkan Ali, Yaz?c? Gözde, Cengiz Mustafa, Karaka? Yusuf, Çelik ?smail, Kars Ay?e, Zorlu Far |
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma. Journal of cancer research and clinical oncology 2022 8 . Lazaridis Lazaros, Schmidt Teresa, Oster Christoph, Blau Tobias, Pierscianek Daniela, Siveke Jens T, Bauer Sebastian, Schildhaus Hans-Ulrich, Sure Ulrich, Keyvani Kathy, Kleinschnitz Christoph, Stuschke Martin, Herrmann Ken, Deuschl Cornelius, Scheffler Björn, Kebir Sied, Glas Mart |
Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. Frontiers in genetics 2024 1 14 1320789. Tonia Carter, Robert K Valenzuela, Srinivasulu Yerukala Sathipati, Rafael Medina-Flor |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: